For safety outcomes, semaglutide and tirzepatide showed lower risks for serious bacterial infections compared to sitagliptin and dulaglutide, respectively
The actual decision involves matching the biological evidence to the clinical picture in front of the physician
Combined with clinical biomarkers like fasting insulin, HbA1c, and kidney function, this information can support a more informed conversation with your provider about whether compounded semaglutide aligns with your individual physiology and safety needs
At Alluring Aesthetics , we offer a medically guided approach to medical weight loss in Colorado Springs , built around real science and personalized care
Other conditions GLP-1 agonists can fight against are hypertension (high blood pressure), heart disease, asthma, high cholesterol, and even some cancers